Articles with "hct recipients" as a keyword



Photo by charlesdeluvio from unsplash

Predictors of impaired antibody response after SARS‐CoV‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study

Sign Up to like & get
recommendations!
Published in 2022 at "American Journal of Hematology"

DOI: 10.1002/ajh.26769

Abstract: HCT recipients reportedly have a high mortality rate after developing COVID‐19. SARS‐CoV‐2 vaccination is generally useful to prevent COVID‐19. However, its safety and efficacy among HCT recipients remain elusive. This large‐scale prospective observational study including… read more here.

Keywords: hct recipients; vaccination; observational study; response ... See more keywords
Photo by kevinjiner from unsplash

A Single Center Experience of Letermovir for the Prevention of CMV Infection in CMV-Seropositive Allogeneic Cell Transplant (Allo-HCT) Recipients

Sign Up to like & get
recommendations!
Published in 2019 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2018.12.339

Abstract: Introduction and Objectives Letermovir (LTV) is the first agent in the class of anti-CMV viral terminase inhibitors and was recently approved in the U.S. for the prevention of CMV infection in CMV-seropositive allo-HCT recipients. In… read more here.

Keywords: allo hct; cmv seropositive; hct recipients; cmv ... See more keywords
Photo from wikipedia

Measuring Patient-Reported Outcomes (PROs) in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients

Sign Up to like & get
recommendations!
Published in 2020 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2019.12.236

Abstract: PROs are increasingly used in HCT to capture symptoms, quality of life, and functional status. At the Cleveland Clinic, PROs are systematically collected prior to ambulatory visits and used in routine clinical care to identify… read more here.

Keywords: time; hct; post hct; pre hct ... See more keywords
Photo from wikipedia

BK Virus-Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplantation (HCT) Recipients with Primary Immunodeficiency

Sign Up to like & get
recommendations!
Published in 2020 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2019.12.345

Abstract: Allogeneic HCT recipients may develop BK virus (BKV)-associated hemorrhagic cystitis (BKV-HC), typically early after engraftment. Yet, BKV levels in urine and blood are not routinely monitored pre- or post-HCT. Among HCT recipients with primary immunodeficiency… read more here.

Keywords: bkv levels; bkv; blood; hct ... See more keywords
Photo by nci from unsplash

Increasing Use of Potentially Inappropriate Medications in Older Allogeneic HCT Recipients Leads to Higher NRM

Sign Up to like & get
recommendations!
Published in 2020 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2019.12.656

Abstract: Background The American Geriatric Society has established criteria (Beers criteria) for Potentially Inappropriate Medications (PIMs) in older (65+y) adults (J Am Geriatr Soc. 2019 Apr;67(4):674-694). The use of PIMs in allogeneic hematopoietic cell transplant (allo-HCT) and… read more here.

Keywords: use; use pims; hct; nrm ... See more keywords
Photo from wikipedia

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?

Sign Up to like & get
recommendations!
Published in 2022 at "Bone Marrow Transplantation"

DOI: 10.1038/s41409-022-01616-7

Abstract: In this issue of Bone Marrow Transplantation, Ogimi and colleagues report on a large cohort of 1027 allogeneic hematopoietic cell transplant (HCT) recipients from a single center infected with respiratory viruses (excluding severe acute respiratory… read more here.

Keywords: risk; infection; isi; hct recipients ... See more keywords
Photo from wikipedia

Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients

Sign Up to like & get
recommendations!
Published in 2018 at "Expert Review of Clinical Pharmacology"

DOI: 10.1080/17512433.2018.1500897

Abstract: ABSTRACT Introduction: Allogeneic hematopoietic cell transplants (allo-HCT) recipients are at the high-risk of reactivation of cytomegalovirus (CMV), and reactivation is associated with significant morbidity and mortality. Although available anti-CMV therapies may be effective for the… read more here.

Keywords: cmv; infection; letermovir prevention; cytomegalovirus ... See more keywords
Photo from wikipedia

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients

Sign Up to like & get
recommendations!
Published in 2017 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofx163.1358

Abstract: Abstract Background The benefit of aerosolized ribavirin (AR) in reducing the risk of progression of RSV infections and RSV-associated mortality in HCT recipients has been recognized, yet there is a paucity of data assessing the… read more here.

Keywords: ribavirin; treatment; rsv infections; hct ... See more keywords
Photo from wikipedia

1573. Discrepancies Between Premortem and Postmortem Diagnoses of Infectious Diseases Found on Autopsy in Hematopoietic Cell Transplantation Recipients at a High-Volume Academic Transplant Center

Sign Up to like & get
recommendations!
Published in 2018 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofy210.1401

Abstract: Abstract Background Hematopoietic cell transplantation (HCT) is a potentially curative treatment option for patients with hematologic malignancies and other diseases but carries a significant risk of infection-related morbidity and mortality. Many of these infections are… read more here.

Keywords: infectious diseases; cell transplantation; hematopoietic cell; found autopsy ... See more keywords
Photo from wikipedia

A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature

Sign Up to like & get
recommendations!
Published in 2022 at "Current Oncology"

DOI: 10.3390/curroncol29010030

Abstract: The management of COVID-19 in hematopoietic cell transplant (HCT) recipients represents a special challenge given the variable states of immune dysregulation and altered vaccine efficacy in this population. A systematic search (Ovid Medline and Embase… read more here.

Keywords: hct recipients; patients undergoing; mortality; hematopoietic cell ... See more keywords